Cardiovascular effects of recreational drugs (cocaine, marijuana, methamphetamines)

Czech version

Authors: Vítovec J.; Špinarová L.; Špinar J.
Authors‘ workplace: I. interní kardioangiologická klinika LF MU a FN u sv. Anny v Brně
Published in: Kardiol Rev Int Med 2019, 21(3): 159-162

Overview

In addition to psychological addiction and brain damage, the use of addictive substances causes a variety of internal organ damage (liver, kidney). Cardiotoxicity is one of the serious manifestations. We provide an overview of the damage to the cardiovascular system in cocaine, marijuana and methamphetamine users.

Keywords:

cardiovascular system – Cocaine – Marijuana – methamphetamine

Sources

1. Connors NJ, Hoffman RS. Experimental treatments for cocaine toxicity: a difficult transition to the bedside. J Pharmacol Exp Ther 2013; 347(2): 251–257. doi: 10.1124/ jpet.113.206383.

2. Schwartz BG, Rezkalla S, Kloner RA. Cardiovascular effects of cocaine. Circulation 2010; 122(24): 2558–2569. doi: 10.1161/ CIRCULATIONAHA.110.940569.

3. Rezkalla SH, Mazza JJ, Kloner RA et al. Effects of cocaine on human platelets in healthy subjects. Am J Cardiol 1993; 72(2): 243–246. doi: 10.1016/ 0002-9149(93)90173-a.

4. Havakuk O, Rezkalla S, Kloner RA. The cardiovascular effects of cocaine. J Am Coll Cardiol 2017; 70(1): 101–113. doi: 10.1016/ j.jacc.2017.05.014.

5. Vítovec J, Špinarová L, Špinar J. Kardiovaskulární účinky marihuany a kokainu. Remedia 2018; 28: 163–165.

6. Mittleman MA, Lewis RA, Maclure M et al. Triggering myocardial infarction by marijuana. Circulation 2001; 103(23): 2805–2809. doi: 10.1161/ 01.cir.103.23.2805.

7. Goyal H, Awad HH, Ghali JK. Role of cannabis in cardiovascular disorders. J Thorac Dis 2017; 9: 2079–2092.

8. Bachs L, Mørland H. Acute cardiovascular fatalities following cannabis use. Forensic Sci Int 2001; 124(2–3): 200–203. doi: 10.1016/ s0379-0738(01)00609-0.

9. Ravi D, Ghasemiesfe M, Korenstein D et al. Associations between marijuana use and cardiovascular risk factors and outcomes: a systematic review. Ann Intern Med 2018; 168(3): 187–194. doi: 10.7326/ M17-1548.

10. Paratz ED, Cunningham NJ, MacIsaac AI. The cardiac complications of methamphetamines. Heart Lung Circ 2016; 25(4): 325–332. doi: 10.1016/ j.hlc.2015.10.019.

11. Won S, Hong RA, Shohet RV et al. Methamphetamine-associated cardiomyopathy. Clin Cardiol 2013; 36(12): 737–742. doi: 10.1002/ clc.22195.